Current status of antimicrobial resistance in Indian healthcare system: combating antimicrobial resistance with precision medicine · Shinde A, Mohan A, Bulusu VM et al.

Introduction

Antimicrobial resistance (AMR) refers to the ability of microorganisms, including bacteria, viruses, fungi and parasites, to resist the therapeutic effects of previously effective antimicrobials (Tang et al., 2023). By 2050, this silent pandemic could cause 10 million mortalities globally, up from 700,00 per year (Ahmed et al., 2024c). High prevalence of AMR in India stems from the extensive use of antibiotics in clinical settings (Gandra et al., 2017). Antimicrobial – resistant pathogens such as Carbapenem-resistant Enterobacterales (CRE), Multi-drug-resistant Gram-negative bacteria (MDR-GNB) such as Acinetobacter baumanii, Pseudomonas aeruginosa and Gram-positive cocci (GPCs) such as MDR Staphylococcus aureus whose management have become complicated, contribute significantly to hospital-acquired infections (HAIs). In (Figure 1) we have provided a graphical representation of current trends in AMR. These infections result in treatment failures, extended length of stays, increased healthcare expenses, and socioeconomic burden, for healthcare facilities (Jean et al., 2022; Kumar et al., 2021). In addition to Hospital acquired infections (HAIs), AMR is a growing problem in outpatient settings, where the prevalence of drug-resistant bacteria in community-acquired infections continues to rise (Alsan et al., 2018). Alarming rise in prevalence of resistant pathogens in OPD settings can be inferred from (Table 1; Figure 2). The WHO published its 2024 priority bacterial pathogens list, which classifies Acinetobacter baumannii, Carbapenem and 3rd generation Cephalosporin resistant Enterobacterales as critical priority pathogens, while Staphylococcus aureus, Pseudomonas, Enterococcus faecium, Shigella spp., and Salmonella spp. as high priority pathogens. It is important to note that these pathogens have consistently been ranked highly antimicrobial-resistant ever since the first WHO report in 2017 (Jesudason, 2024; World Health, 2024a).

Figure. (A–F) Heatmap showing year wise trends of antimicrobial resistance in key pathogens data extracted from NARS-Net annual reports 2018-23. (See the original article for the figure.)

Table. Priority pathogens isolated and reported in OPD Settings; Data extracted from NARS – Net Annual Reports 2018 – 23. (See the original article for the full table.)

Figure. Year-wise prevalence trends of priority pathogens in OPD settings, adapted from NARS-Net annual reports 2018-23. (See the original article for the figure.)

Several factors contribute to increase in AMR in India which includes: various secondary hospitals’ poor antimicrobial stewardship program due to poor resource availability, the absence of educational programs to fill the knowledge gap of healthcare professionals (Mathew et al., 2020), over-the-counter (OTC) dispensing of antibiotics, and patients refilling antibiotics using older prescriptions (Jani et al., 2021). In addition, an important factor in the emergence and spread of AMR is the improper use of antibiotics and lack of monitoring. To address this growing issue, the Indian Council of Medical Research (ICMR) developed evidence-based treatment guidelines. The updated information on treatment guidelines together with the dosage, mode of administration, and length of therapy for skin infections, soft tissues, bones, and joints, are included in the second edition. To provide uniformity in the management of different infectious diseases, the “Treatment guidelines for antimicrobial use in common syndromes” seek to justify the use of antibiotics (Aggarwal et al., 2019). Before starting antimicrobial therapy, antimicrobial susceptibility testing must be carried out extensively, especially to estimate minimum inhibitory concentration (MIC). Together with personalized medicine approaches, such as pharmacogenomics, that is treatment based on genetic profiling of patients and therapeutic drug monitoring of antimicrobial drugs, should be included. The use of narrow-spectrum antibiotics provides a targeted antimicrobial effect against specific pathogens, thus limiting the development of antimicrobial resistance. This approach ensures that antibiotics are administered precisely, within the minimum inhibitory concentration (MIC) levels, achieving optimal therapeutic efficacy. It simultaneously prevents drug-related adverse effects, including drug-induced liver injuries (DILIs), nephrotoxicity, ulcers, rashes, vomiting, and gastric upset (Roberts et al., 2012). If appropriate solutions are not implemented, AMR could compromise the sustainable development goals (SDGs) and cause millions of people to continue living in poverty by 2030 (World Health, 2021). Strong measures to prevent the spread are crucial, as evidenced by the prevalence of resistant pathogens in India (Ravishankar et al., 2021).

A recent systematic review on Knowledge, Attitudes and Practices (KAP) related to AMR reported that knowledge levels were highest among doctors, followed by nurses and pharmacists. However, despite relatively good theoretical knowledge, a noticeable gap persists in the translation of this knowledge into appropriate clinical practice among healthcare providers in India. Moreover, the review highlighted that the majority of published literature predominantly focuses on hospital-based infections, indicating a clear gap in evidence related to AMR in outpatient and community settings (Rana et al., 2024).

This review provides a unique perspective by integrating antimicrobial resistance (AMR) data from Indian healthcare, with a particular emphasis on outpatient settings that are often overlooked in existing literature. Unlike previous reviews that primarily focus on hospital-acquired infections, this article explores the community dimension of AMR and its implications for public health. Furthermore, it introduces an innovative framework linking AMR mitigation strategies with precision medicine approaches, including pharmacogenomics, metabolomics, proteomics, and transcriptomics. By combining multi-omics insights with national surveillance data and stewardship initiatives, this review highlights the translational potential of personalized antimicrobial therapy tailored to the Indian healthcare ecosystem. This integrated perspective offers a novel direction for AMR research and policy, bridging the gap between genomic science and clinical application in resource-limited settings.